These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Lack of antinociceptive efficacy of intracerebroventricular [D-Ala2,Glu4]deltorphin, but not [D-Pen2,D-Pen5]enkephalin, in the mu-opioid receptor deficient CXBK mouse. Raffa RB, Martinez RP, Porreca F. Eur J Pharmacol; 1992 Jun 17; 216(3):453-6. PubMed ID: 1330585 [Abstract] [Full Text] [Related]
10. Up-regulation of brain N-methyl-D-aspartate receptors following multiple intracerebroventricular injections of [D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin II in mice. Bhargava HN, Kumar S, Bian JT. Peptides; 1997 Jun 17; 18(10):1609-13. PubMed ID: 9437723 [Abstract] [Full Text] [Related]
17. Effects of structural modifications of N-CPM-normorphine derivatives on agonist and antagonist activities in isolated organs. Riba P, Tóth Z, Hosztafi S, Friedmann T, Fürst S. Acta Biol Hung; 2003 Sep 17; 54(2):177-81. PubMed ID: 14535623 [Abstract] [Full Text] [Related]
18. Pseudoirreversible binding characteristics of [D-Ala2,Glu4]deltorphin and its Cys4 substituted derivative to delta-opioid receptors. Wild KD, Horan PJ, Misicka A, Lipkowski A, Haaseth RC, Matsunaga TO, Hruby VJ, Toth G, Borsodi A, Yamamura HI. Eur J Pharmacol; 1993 Jun 15; 246(1):25-31. PubMed ID: 8394818 [Abstract] [Full Text] [Related]
19. Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats. Crook TJ, Kitchen I, Hill RG. Br J Pharmacol; 1992 Oct 15; 107(2):573-6. PubMed ID: 1330187 [Abstract] [Full Text] [Related]
20. Spinal delta opioid receptor subtype activity of 6-monoacetylmorphine in Swiss Webster mice. Rady JJ, Baemmert D, Takemori AE, Portoghese PS, Fujimoto JM. Pharmacol Biochem Behav; 1997 Feb 15; 56(2):243-9. PubMed ID: 9050081 [Abstract] [Full Text] [Related] Page: [Next] [New Search]